Clinical Trial Update: Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

View source ↗

Summary

A completed clinical trial comparing apixaban to warfarin in patients with non-valvular atrial fibrillation who have a higher risk of bleeding, evaluating safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)
• Warfarin (warfarin)

Snippet

Sponsor: Pfizer | Conditions: Non-valvular Atrial Fibrillation | Status: COMPLETED | Results posted: 2024-07-11